News | May 26, 2015

VeriTeQ Awarded New U.S. Patent for Wireless Molecular Sensor System and Process

Patent to be used in development of bio-sensing microchip applications

May 26, 2015 — VeriTeQ Corp. announced that it has been awarded a U.S. Patent for Wireless Molecular Sensor System and Process. The company intends to utilize the patent in the development of future bio-sensing microchip applications, initially focused on its radiation dose measurement technologies used during cancer treatment.

This newest patent covers methods and systems for measuring and wirelessly communicating particular molecular levels using an implantable sensor device operable without the use of batteries. These implantable biosensor systems use radio frequency technology to wirelessly transmit information between a transponder passively powered on a chip and a remote transponder. Information transmitted via this wireless communication system quantifies a physiological metric with respect to the levels of specific molecules measured by the biosensor.

The company plans to apply this patent in conjunction with its future radiation dose measurement products, to be used during cancer treatment therapies. Within its broad intellectual property portfolio, the company has an existing patent for implantable sensors that dynamically monitor multiple biological and physiological parameters, such as temperature to monitor hyperthermia.

For more information: www.veriteqcorp.com

Related Content

More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
Top Score in Multiple Brain Metastases TROG 2018 Treatment Plan Study Achieved With Accuray Precision

Image courtesy of Accuray Inc.

News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
Mercy Signs Multi-System, Multi-Hospital Agreement for Accuray Radiotherapy Systems
News | Radiation Therapy | May 16, 2018
Accuray Inc. signed a multi-system, multi-hospital agreement with Mercy for the acquisition of Accuray Radixact and...
Samsung Adds S-Vue 3.02 Imaging Engine to GC85A Digital X-ray for Lower Dose
News | Digital Radiography (DR) | May 10, 2018
As part of a growth vision centered on improving patient care quality and safety, Samsung has incorporated the S-Vue 3....
ViewRay Unveils New Soft Tissue Visualization Technologies for MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | April 30, 2018
ViewRay Inc. announced new magnetic resonance imaging (MRI) technologies under development for its MRIdian Linac...
MedStar Georgetown Conducts World's First Hyperscan Proton Therapy Treatment
News | Proton Therapy | April 27, 2018
For the first time, cancer patients in the Washington, D.C. metropolitan region have access to proton therapy, now...
Designed to support a broad range of planning and delivery technologies, SunCheck 2.0 streamlines and standardizes workflows, allowing greater overall focus on patient safety.
Technology | Quality Assurance (QA) | April 27, 2018
Sun Nuclear Corp. released significant new functionality for its SunCheck Platform for patient and machine quality...
RayStation Users Win Inaugural Treatment Planning World Championships
News | Treatment Planning | April 27, 2018
In the first World Championships of Treatment Planning, arranged by radiation oncology analytics company ProKnow and...
Brainlab Introduces New Hi-Res Planning Algorithm for VersaHD
News | Treatment Planning | April 24, 2018
Brainlab announced the implementation of a software solution that can achieve better radiation dose conformity around...
Overlay Init